Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset

INTRODUCTION: We assessed the risk factors and outcome of COVID-19 in patients with autoimmune rheumatic diseases(AIRD) who contracted infection while on background treatment with tofacitinib. METHODS: This is a non-interventional, cross-sectional, questionnaire based telephonic study which included...

Descripción completa

Detalles Bibliográficos
Autores principales: Chebbi, Pramod, Shobha, Vineeta, Rao, Vijay K, Haridas, Vikram, Janardana, Ramya, Pinto, Benzeeta, Kumar, Sharath, Patil, Abhishek, Tekkatte, Roopa, Salanke, Manasa, Mahendranath, K M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369741/
https://www.ncbi.nlm.nih.gov/pubmed/37496101
http://dx.doi.org/10.1186/s41927-023-00345-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369741/
https://www.ncbi.nlm.nih.gov/pubmed/37496101
http://dx.doi.org/10.1186/s41927-023-00345-8

Ejemplares similares